Hermann Einsele

92PUBLICATIONS
507CO-AUTHORS
Gene and molecular therapyAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (92)

|Jul 06, 2026
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Jun 25, 2026
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Apr 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure.

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Mar 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.

Umair Munawar, Johanna Thurner, Silvia Nerreter

|Mar 26, 2026
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy.

Sofie-Katrin Kadel, Lukas Scheller, Alexander M Leipold

Pageof 16

Frequent Collaborators

27 joint publications

Martin Kortüm

22 joint publications

Leo Rasche

13 joint publications

Michael Hudecek

11 joint publications

Maria-Victoria Mateos